Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124549082 | 12454908 | 2 | F | 20160514 | 20160627 | 20160610 | 20160720 | PER | US-PFIZER INC-2016262543 | PFIZER | 24.00 | YR | M | Y | 63.50000 | KG | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124549082 | 12454908 | 1 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 500 MG, 1X/DAY (250MG CAPSULE BY MOUTH TWO FIRST DAY THEN ONCE DAILY) | 1505007813 | 50670 | 500 | MG | CAPSULE, HARD | QD | |||||
| 124549082 | 12454908 | 2 | SS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 250 MG, 1X/DAY (250MG CAPSULE BY MOUTH TWO FIRST DAY THEN ONCE DAILY) | 1505007813 | 50670 | 250 | MG | CAPSULE, HARD | QD | |||||
| 124549082 | 12454908 | 3 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 25MG TABLET BY MOUTH TWICE DAILY | 0 | 25 | MG | TABLET | BID | ||||||
| 124549082 | 12454908 | 4 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | USUALLY TAKES IT ONLY ONCE A DAY | 0 | TABLET | QD | |||||||||
| 124549082 | 12454908 | 5 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | 995233 | 0 | 10 | MG | QD | ||||||
| 124549082 | 12454908 | 6 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 5 MG, 2X/DAY (5MG LIQUID BY MOUTH TWICE DAILY) | 995233 | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124549082 | 12454908 | 1 | Sinusitis |
| 124549082 | 12454908 | 3 | Hypersensitivity |
| 124549082 | 12454908 | 5 | Sinusitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124549082 | 12454908 | Abdominal pain upper | |
| 124549082 | 12454908 | Abnormal faeces | |
| 124549082 | 12454908 | Chills | |
| 124549082 | 12454908 | Condition aggravated | |
| 124549082 | 12454908 | Decreased appetite | |
| 124549082 | 12454908 | Drug ineffective | |
| 124549082 | 12454908 | Fatigue | |
| 124549082 | 12454908 | Gastrointestinal disorder | |
| 124549082 | 12454908 | Muscle fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124549082 | 12454908 | 2 | 20160428 | 0 | ||
| 124549082 | 12454908 | 3 | 201511 | 0 | ||
| 124549082 | 12454908 | 5 | 20160511 | 0 |